Our results revealed tumor AMP (Figure 4A), ADO (Figure 4B) and INO (Figure 4C) content were significantly reduced only in tumors which received combination treatment (RFA+AB680) when compared to RFA alone (p<0.05). This evidence concerns the gene ADO and neoplasm.